Middletown, NJNCT07449208Now EnrollingIRB Ready

Esophageal Malignant Neoplasm Primary Clinical Trial in Middletown, NJ

Access cutting-edge esophageal malignant neoplasm primary treatment through this clinical trial at a research site in Middletown. Study-provided care at no cost to qualified participants.

Sponsored by Memorial Sloan Kettering Cancer Center

Quick Self-Assessment

See if you qualify for this Middletown location

Preparing your pre-screening questions…

Expert Care in Middletown

Access esophageal malignant neoplasm primary specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related esophageal malignant neoplasm primary treatment provided free

Apply for This Middletown Location

Check if you qualify for this esophageal malignant neoplasm primary clinical trial in Middletown, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Middletown

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Middletown site if eligible
  4. 4Begin participation

About This Esophageal Malignant Neoplasm Primary Study in Middletown

The main purpose of this study is to look at how often anastomotic leaks happen in participants who are at high risk of these leaks and are eligible to receive gastric preconditioning by percutaneous angioembolization before an esophagectomy.

Sponsor: Memorial Sloan Kettering Cancer Center

Who Can Participate

Inclusion Criteria

Documentation of Disease
Patients must have pathologically confirmed esophageal malignancy requiring esophagectomy.
Patients must also have risk factors for anastomotic leak:
Previous foregut or bariatric surgery (gastric sleeve or gastric bypass), but excluding fundoplication-only surgery OR
Salvage esophagectomy OR
Planned cervical anastomosis OR
Two or more comorbidities:
Diabetes, obesity, coronary artery disease, vascular disease (including celiac stricture or atherosclerosis, significant aortic disease, or any previous diagnosis of peripheral arterial disease), steroid use, hypertension, current or former smoker, renal insufficiency, and heart failure.
Definition of Disease
Patients must have pathologically confirmed esophageal malignancy requiring esophagectomy and risk factors for anastomotic leak, as described above.
Patients must be candidate and have agreed to receive gastric preconditioning procedure
Prior Treatment o There are no requirements with regard to prior treatment.
ECOG Performance Status of ≤ 2 (See Appendix I for performance status criteria)

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Middletown?

Yes, this clinical trial (NCT07449208) has an active research site in Middletown, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Esophageal Malignant Neoplasm Primary Treatment Options in Middletown, NJ

If you're searching for esophageal malignant neoplasm primary treatment options in Middletown, NJ, this clinical trial (NCT07449208) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Middletown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced esophageal malignant neoplasm primary specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all esophageal malignant neoplasm primary clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Middletown, NJ

See all ankylosing spondylitis clinical trials recruiting in Middletown — not just this study.

Browse Ankylosing Spondylitis Trials in Middletown

Ready to Join in Middletown?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Middletown, NJ